IR 05000290/1996001
| ML20216G613 | |
| Person / Time | |
|---|---|
| Site: | 05000290, 03034015 |
| Issue date: | 08/12/1997 |
| From: | Jonathan Montgomery NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION IV) |
| To: | |
| References | |
| 50-29096-01MD, 50-29096-1MD, 572535, NUDOCS 9709150258 | |
| Download: ML20216G613 (20) | |
Text
{{#Wiki_filter:, _. pDR w mQatnGudia:Gi6mdiDiDidiDiDiGiQianoiHOiu iciBDiH5i5iBiciBinici3riniciroicifrentatOtcrJrg
Ig NRC FORM 374
- U.S NUCLEAR RECULATORY COMMISslON l*
p Amendment No. 2 R
lbl I g MATERIALS LICENSE h' b' hl
, l g l Parsuant to the Atomic Energy Act of 1954, as amended, the Energy Reorgan: ration Act of 1974 (Public Law 93-438), and Title 10, Co g l Federal Regulations, Chapter I, Parts 30,31,32,33,34,35,36,39,40, and 70, and in tr:iance on statements and representations heretofore made !g l g l by the licensee, a license is hereby issued authorizing the licensee to receive, require, possess, and transfer byproduct, source, and special nuclear Cl g material designated below; to use such material for the purpose (s) and at the place (s) designated below; to deliver or transfer suci. material to
~ i d persons authorized to receive it in accordance with the regulations of the applicable Pan (s). nis license shall be deemed to contain the conditions Il f 5l
- j specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subbet to al 4; Nuclear Regulatory Cornmission now or hereafter in effect and to any conditions specified below.
El , 4; El !;! In accordance with telefacsimile dated h
- "'**
I
Alaska Radiological Pharmacy I td.
0-29096-OlMD is amended in ' g its entirety to read as follows: g
2, E
4201 Lake Otis Parkway 4. Expiration Date April 30, 2001 E
- {
Anchorage, Alaska 99508 h R er n e No.
030-34015 Ig 6 7, Chemical and'or Physical 8. Maximum Amount that Licensee g! h . Byproduct Source,and'or Special Nuclear Material Form May Possess at Any One Time g g Under 'Ihis License j
El
E e! E
W I B E l A.
Any byproduct material A. Unsealed A.
Molybdenum-99 35.0 Ci g g listed in 8.A. which is Technetium-99m 35.0 Ci y g initially distributed Xenon-133 1.0 Ci g
in accordance with a Strontium-89 495.0 mci l
specific license issued Phosphorus-32 50.0 mci pursuant to 10 CFR1 Rhenium-186 500.0 mci ! -
32.72 or equivalent Iodine-131 1.0 Ci
Agreement State ~ regulations l ll g B.
Technetium-99m B. Unsealed B.
35 curies E
E l f C.
Strontium-89 C. Unsealed C.
50 millicuries N D.
Phosphorus-32 0. Unsealed D.
50 millicuries E, g ( E.
Rhenium-186 E. Unsealed E.
100 millicuries { g W F.
Ary byproduct material F. Prepackaged units F.
50 millicuries $ il listed in 10 CFR for in vitro
31.11(a) diagnostic tests l ! / g u - , I E a N N
E M q Ej lEllkbl[klilhII[lNk xh .n 9709150258 970912 !'U I PDR ADOCK 03034015 U! 8; __ PDR EDwG% 3 3 f Twgy p y X y 3 3 3 m Lm 3 5 =Tys m m mtE 2 m Q hmted on rencled paper
5 g-=was m_aunusumusuronstmunfimEimmtwueri amimmcind&ismsntsmants33nici W u gll *N.7C FORM 374A !(5 ' U.S. NUCLE AR RE!ULATORY Commission PAGE
or
pacts I Gense sumer l y{ 50-29096-OlMD g y! ll p MATERIALS LICENSE oxtei or Reference Numwr E I y SUPPLEMENTARY SHEET 030 34015 Ej R E i W! Amendment No. 2 El N El R, Ei M! El N
N G.
Any byproduct material G.
Any sealed source G.
50 millicuries $ authorized under 10 CFR listed in 35.67(a) " 35.57(a) that has been El manufactured,
Nj labeled, packaged, E, % and distributed in El Nl' accordance with a k' W specific license El issued pursuant to El 10 CFR 32.74 or El Mg equivalent El M regulations of any E1 N Agreement State E N
H.
Any byproduct mate' rial H. Any sealed source H.
500 millicuries i g listed in Sections that has been i g 35.400 and 35.500 of manufactured, k y 10 CFR Part 35 labeled, packaged, is y , and distributed in d ' y accordance with a i specific license j i issued pursuant to gl 10 CFR 32.74 or El E equivalent i E Agreement State
regulations j p I.
Uranium (Depleted in I. Metal encased in I.
180 kilograms E y the isotope stainless steel E y Uranium-235) E
E g; 9.
Authorized use: E af E ' y A. through E.
Preparation and distribution of radioactive drugs and E y redistribution of Mo99/Tc991 generators to authorized E i g recipients.
El g.
E i ! l y F.
Redistribution to specific licensees or general licensees pursuant to 10 CFR lE El y 31.11 provided the packaging and labeling remain unchanged.
E N G.
Instrument calibration. Redistribution of sources to specifically authorized !E y y recipients.
Pursuant to 10 CFR 32.74, the licensee is autherized to E y redistribute sources to persons licensed pursuant to 10 CFR 35.57(a) or under E , y equivalent licenses of Agreement States.
ni s W l5l N '5l B $1 M l5l W 15l ikn.cr.n., - - .. - - ...... - - -.. - - - - -n i - - - - - -w+ - - - - = = = = J!
r )ggggungUggagBU50BT W W W W W W W_MUC WL 40BL)RilBfC4UBlyj' -- lgl U.S. NUCLEAR REcVLATOQY CoMMisSloN PAGE
OF
mGES NRC FORM 374A - P Liceme Number [ 50-29096-OlMD gl MATERIALS LICENSE Met or Refererc Number El SUPPLEMENTARY SHEET 03f-34015 El E Amendment No. 2 E, d E E h9.
Authorized use (Continued): g s H.
Redistribution of sealed sources as received from the manufacturer in the E y manufacturer's original packaging and shielding and accompanied by the E ' q manufacturer's approved instructions to authorized recipients for use and g g storage, y I.
As shielding for molybdenum-99/ technetium-99m generators.
l l k Pursuant to 10 CFR 32.71, 32.72, 32.74, the licensee is authorized to distribute l lj the byproduct material described in Items 6 and 7 and prepared in accordance with y this license to persons licensed pursuant to Section 10 CFR 31.11, or Sections , g W 35.57, 35.100, 35.200, 35.300, 35.400, and 35.500 of 10 CFR Part 35, or under y equivalent Agreement State licenses, y ! CONDITIONS M - N 10.
A.
Licensed material shall be used only at the licensee's facility located at l 4201 Lake Otis Parkway, Anchorage, Alaska.
g W B.
Licensed material for DECOMMISSIONING PURPOSES ONLY may be use at 2000 W.
l W International Airport Road, Suite A-ll, Anchorage, Alaska.
- M R 11.
A.
Licensed material shall be used by, or under the supervision of: l ' Hl 1) authorized nuclear pharmacists: Peter C. Iverslie, R.Ph ; E Bj Steven C. Dragotakes, R.Ph.; Jeffery S. Cone, R.Ph.; E sj Xathleen M. Taylor, R.Ph.; or Ronald J. C'allahan, R.Ph.; Yunga E El
Vercelline, R.Ph.
i lg IE M 2) a pharmacist working or designated as an authorized nuclear pharmacist ! E in accordance with 10 CFR 32.72(b)(2) and (4).
- W
" p.
B.
The Radiation Safety Officer for this license is Peter Iverslie, R.Ph.
E N' R y 12.
Sealed sources containing licensed material shall not be opened or sources removed E y from, source holders by the licensee.
E %
y 13.
A.
Sealed sources shall be tested for leakage and/or contamination at intervals E, y not to exceed 6 months or at such other intervals as specified by the El certificate of registration referred to in 10 CFR 32.210.
El y! g! 'tl g B.
Notwithstanding Paragraph A of this Condition, sealed sources designed to El gl emit alpha particles shall be tested for leakage and/or contamination at El intervals not to exceed 3 months.
gi ~ N LMl*WJ'WNRWENNMEN"?WJFN ' si s ?X NE??????S N ?' I '
\\ ywamunusumusumunust w w w w wmLausswam.auna LauUumififiLwudfifiTJsT_afiUEifilw1NLy i NRo FORM 374A U.S. NUCLEAR REoVLAToRY Commission PAGE
OF
PoGES pl
N f Licenw Number f 50-29096-OlMD gl I MATERIALS LICENSE DocLet or Reference Numter g SUPPLEMENTARY SHEET 030-34015
El Amendment No. 2 El El E E E n, E fi 13.
(Continued) N C.
In the absence of a certificate from a transferor indicatin that a leak test g 3.
has been made within 6 months )rior to the transfer, a seal!d source received f from ancther person shall not se put into use until tested, g , gl D.
Sealed sources need not be leak tested if: l (i) they contain only hydrogen-3; or l (ii) they contain only a radioactive gas; or l (iii)the half-life of the isotope is 30 days or less; or E g E M (iv) they contain not more than 100 microcuries of beta and/or gamma emitting
material or not more than 10 microcuries of alpha emitting material; or g g
(v) they are not designed to emit alpha particles, are in storage, and are l N not being used.
However, when they are removed from storage for use or g - 3; transferred to another person, and have not been tested within the ' M' required leak test interval, they shall be tested before use or El ! transf:r. No sealed source shall be stored for a period of more than 10 El
years without being tested for leakage and/or contamination.
El a El i E.
The leak test shall be capable of detecting the presence of 0.005 microcurie E ! g! of radioactive material on the test sample.
If the test reveals the presence E g of 0.005 microcurie or more of removable contamination, a report shall be E y filed with the U.S. Nuclear Regulatory Commission in accordance with E y 10 CFR 30(b)(2), and the source shall be removed immediately from service and E y decontaminated, repaired, or disposed of in accordance with Commission E y regulations.
The report shall be filed within 5 days of the date the leak R g! test result is known with the U.S. Nuclear Regulatory Commission, Region IV, E y! 611 Ryan Plaza Drive, Suite 400, Arlington, Texas 76011, ATTN: Director, E g Division of Nuclear Materials SW '.y.
The report shall specify the source E . a involved, the test results, and rective action taken.
E a E j F.
Tests for leakage and/or contamination shall be performed by the licensee or E Fl! _ by other persons specifically licensed by the Commission or an Agreement E State to perfora such services.
E a! El
14.
The licensee shall conduct a physical inventory every 6 months to account for all El J sources and/or devices received and possessed under the license.
El lkf El a! El )ll E !i a E g C - _ -
plAw3ususuiDausususustw m unsuifiosuluiMGiMUEanusCianusDiniRiniMusususu f *RC FORM 374A N U.S. NUCLEAR REoVLATORY CoMMisslON PoGE
or
PSGES g h gl Lkeme Numbr i g 50-29096-OlMD gl
f p MATERIALS LICENSE tutei or Reference Number El Ig SUPPLEMENTARY SHEET 030-34015 El g! E; , y Amendment No. 2 E ' y !l W E g.
R
E 15.
The licensee is authorized to transport licensed material only in accordance with g the provisions of 10 CFR Part 71, " Packaging and Transportation of Radioactive E Material," g.
U 16.
Radioactive waste may be picked up from the licensee's customers and disposed of g f in accordance with the procedures, statements, and representations in application g; dated March 14, 1996.
y g M 17.
The licensee is authorized to hold radioactive material with a physical half-life !
of less than 65 days for decay-in-storage before disposal in ordinary trash g provided: g
A.
Radioactive waste to be disposed of in this manner shall be held for decay a l minimum of 10 half-lives.
g M B.
Before disposal as ordinary trash, byproduct material shall be surveyed at f N the container surface with.the appropriate meter set on its most sensitive
g scale and with no interposed shielding to determine that its radioactivity H
cannot be distinguished from background. All radiation labels shall be [ R removed or obliterated, j M C.
Generator columns shall be segregated so that they may be monitored h
separately to ensure decay to background levels prior to disposal.
j - H ' A D.
A record of each disposal permitted under this License Condition shall be !
retained for 3 years.
The record must include the date of disposal, the date l "
on which the byproduct material was placed in storage, the radionuclides l M disposed, the survey instrument used, the background dose rate, the dose rate
measured at the surface of each waste container, and the name of the E y individual who performed the disposal.
! M ' I g 18.
In addition to the possession limits in Item 8, the licensee shall further !l gl restrict the possession of licensed mattrial to quantities below the minimum limit a I g specified in 10 CFR 30.35(d) and 40.36(b) for establishing decommissioning a y financial assurance.
$l 'jg t' E ~ h ! I g
l! E' i ' E $ E q E l9 El, ls El
Yl
!l W si < -l l "l l !l
1 _. ---
- --- :--------- '
- .. -. _.. - - - XW W>N_IBMIJfLRLWi Tilk.lRGDE.RGGUU.Mi.35Gi3L18GGGLPGilRLlEGGiWLWiWiWGlMLWp , NRC FOnM 374A
U.S. NUCL E AR REQULA10RY COMMISSloN mGE
OF
MGES l[p , ' Liceme Number 50-29096-OlMD gl MATERI ALS LICENSE Met or Reference Number (! SUPPLEMENTARY SHEET 030-34015 El, E i
Amendment No. 2 El g: n E B E R E E " 19.
Except as specifically provided otherwise in this license, the licensee shall g cc: duct its program in accordance with the statements, representations, and g pr cedures contained in the documents, including any enclosures, listed below.
g, 'i.e U.S. Nuclear Regulatory Commission's regulations shall govern unless the i g-statements, representations, and procedures in the licensee's application and g correspondence are more restrictive than the regulations, g.
t A.
Product labels submitted with application dated November 21, 1995 g B.
Application dated March 14, 1996 g g ,i C.
Letter dated March 25, 1996 $ D.
Telefacsimile received March 29, 1996 g hl g E.
Facility diagram received April 2, 1996 g F.
Letter dated November 21, 1996 3l G.
Telefacsimile dated February 10, 1997 N H.
Telefacsimile dated April 11, 1997 i g f g I.
Telefacsimile dated July 25, 1997 g W E M
i g! B g E g E l gl i g
E g! i fl
M I l g e d-B al E j& l B R hl t
FOR THE U.S. NUCLEAR REGULATORY COMMISSION [ 'lg i i E.
Date AUG 12 W By hh I I to-e Ej paterials Bran'ch' # ~ / i' i Region IV, WCF0 i % Walnut Creek, California 94596
%y
e k ? d
gl. E.
W e gI E k7*nwnwnm anensnwnenwne - = = = = = = = = = <*nemenk = = = = = = = = = -* * = = = * * = = = "
_ _ _ _.., - _ -. .... .. ..... -- -- - - - - -- - ,
s . -
o i, 1NFhbik....FhLTS , etiettN.
....... ........ , ticen..re.,gna,enterancs, ARM g a. g :,02soo . , ne ionai ticen in, section.
- y,CM 'Ed84 DNJ7*n"l'iurmm I_' / '." ? C r;l l
- 3 ;
- .i.:.:. ::::::::... ~..n.
,,...::: : LIC[NSE FEE TRANSMITTAL s. nes10N TV-kM fo hpk hh ifekh ' A ASKA RADIOLOGICAL PHARMACY LTD.
DN(et'ho: b 15
i n t 2.
gEATTACHED g . CEkko.. CM t 3. COMMENTS O h f / Ened f r a ;> g _.- l t ' nklestone03tyhD - B. LIC[NSE FEI MANAGEMENT BRA t eck w& entered / r/) , l 1.
Fee Category and Amou [L J . I) ke 2. ge jeePaid, licat 5 may be processed for: fi$$e ! 3.
OTHER Si \\ c'gned l cvjy l Log _ _ _ _ %3u _ S 3fdC.
Remitter _ _ Check No.dSb__b.Ib .. - -.. _ _ _. ___ .b_ _ _ _-- ^' Amount fee Catc2ory M k___.
._ 1 Type of fee. _ _ _.....b T ' Date Check flec'd._ / Daty,ld /E _. _ / Mf)jhyf -..l C3nplated. I . Byr[ .._.
-
~
. NRC FORM 677 U.S. NUCLEAR RE7ULATORY COMMIS$10N U*M LICENSE FEE AND DEBT COLLECTlON BRANCH . OfVislON OF ACCOUNilNG AND FINANCE . LICENSE FEE REQUIREMENTS OFFICE OF THE CONTROLLER U.S. NUCLEAR REGULATORY COMMISSION WASHINGTON, DC 20666 4001 TYPE OF ACTION O NEW UCENSE RENEWAL OF UCENSE ALASKA RADIOLOGICAL PHARMACY, LTD.
@ AMENDMENT TO UCENSE 2000 WEST INTERNATIONAL AIRPORT ROAD SUITE A11 REQUESTED DATE ANCHORAGE, AK 99502 7 25-97 UCENSE NUMBER 50-29096-01MD CONTROL NUMBER 572535 ATTN: RITA MESSIER, LFARB, T9E10 1. APPLICATION FEE DUE IL FEE NOT REQUIRED Your request for a heensing action is subject to the fee (s)in the category (ies) not:d below in accordance with Sechon 170 31 of the enclosed Federal Enclosed is Check No.
which accompanied your Register notice. Payment of the fee is required prior to the issuance of the request. The fee is not required because: license,ienewel, or amendment.
[g'M APPUCATION RENEWAL AMENDMENT g We received your Check No.
In payment of 3C $ s s 520.00 the fee.
S S $
$ $ The Uconsing staff has informed us that your request is to be g g g considered as a continuatum of your request dated S
5 , Control No.
5
0 Y'"""**'*****'"*dP'''''**""Y"' s
g request, Control No.
S $ IIL CHECK RETURNED FEE (s) DUE s 520.00 0
- * * ' '
"* PAYMENT RECEIVED
by the bank for.
AMOUNT DUE s 520.00 C INSUFFICIEN' FUNDS OX Your request was received without the prescribed appkcation fee.
ACCOUNT CLOSED ] We rece6ved your Check No.
in the amount of _,, $ Payment of the additional fee noted above is required.
MAIL THE REPLACEMENT CHECK TO THE ADDRESS USTED AT THE Your request will increase the scope of your license program.
TOP OF THIS FORM AND REFERENCE THE ABOVE CONTROL Therefore, your request is subject to the app 0 cation fee (s) noted above.
NUMBER, Refer to Section 170.31 and Footnote 1(d)(2).
IV. LICENSE ISSUED WITHOUT THE REQUIRED FEE Your license expired prior to the receipt of your application for renewal. C Ucense No.
. Amendment No, , issued on Therefore, your request la subject to the application fee (s) noted above.
Refer to Section 170,31 and Footnote 1(a).
was issued without the required fee being collected. The fee required is noted in Section 1 of this form.
MAKE PAYMENT OF THE FEE (S) TO THE U.S. NUCLEAR The scope of your licensed program was increased, Therefore, your REGULATORY COMMISSION AND MAIL THE PAYMENT TO THE request is subject to the opplication fee (s) noted in Section 1 of this form.
ADDRESS USTED AT THE TOP OF THIS FORM. IF WE DO NOT Refer to Section 170.31 and Footnote 1(d)(2).
RECEIVE A REPLY FROM YOU WITHIN 30 CALENDAR DAYS FROM THE DATE LISTED BELOW,WE SHALL ASSUME THAT YOU 00 NOT Because of the urgency of your request, the license was issued without WISH TO PURSUE YOUR APPUCATION AND WILL VOID THIS remittance of the prescribed fee noted in Section 1 of this form.
ACTION.
/ , SIGNATURE = LICENSE FEE ANALYST LFDCB afDDCB/ Distnbution: OC/DAF RF DATE REMessier )@fy\\/. Pgneing Fee Flie OC/DAF/SF Re(.on W(LF 3 2 7) r RITA MESSIER 7/28/97 LFARS RF (2) 7-2847 CFo MtC FORM 577 0 96) torm wee emcwomcally produced try Ehte Fedefal Forms, mc J
o.
/ /*"%
. g t UNITED STATES ). NUCLEAR RE00LATORY COMMISSION .-
REGION IV
I* %.,,,. Walnut Creek Field Office 1450 Maria Lane Walnut Creek, Cahfomia 94596-5368 AUG 12 397 Alaska Radiological Pharmacy Ltd.
ATTN: Peter C. lverslie 2000 W. International Airport Road Suite A 11 i Anchorage, Alaska 99502 SUBJECT: LICENSE AMENDMENT Please find enclosed amendment 2 to Licer$se No. 50-29096-01MD. You should review this license carefully and be sure that you understand all conditions. Please note that I have included both your old and new locations in Condition 10 of this amendment. Once you have completed the decommissioning of your former location, you need to notify this ' office and ' request an amendment to remove the address from Condition 10. This request
must be accompanied by your decommissioning results as specified in NUREG/BR 0241, if l you have any questions, please contact me at 510-975-0249.
NRC expects licensees to conduct their p.ograms with meticulous attention to detail and a ,
hi h standard of compliance. Because of the serious consequences to employees and the
public which can result from failure to comply with NRC requirements, you must conduct your program involving radioactive materials in accordance with the conditions of 9our NRC < license, representations made in your license application, and NRC regulations, in particular, note that you must: 1.
Operate in accordance with NRC regulations 10 CFR Part 19, " Notices, Instructions ' and Reports to Workers: Inspection and Investigations," 10 CFR Part 20, i " Standards for Protection Against Radiation," and other applicable regulations, d 2.
Possess radioactive material only in the quantity and form indicated in your license.
3.
Use radioactive material only for the purpose (s) indicated in your license.
4.
Notify NRC in writing of any change in mailing address (no fee required if the j location of radioactive material remains the same).
- -
5.
Request and obtain written NRC consent before. transferring your license or any right thereunder, either voluntarily or involuntarily, directly or indirectly, through transfer of control of your license to any person or entity. A transfer of control of your license includes not only a total change of ownership, but also a change in the . controlling interest in your company whether it is a corporation, partnership, or . other entity, in addition, appropriate license amendments must be requested and ' obtained for any other planned changes in your facility or program that are contrary to your license or contrary to representations made in your license application, as 4' well as supplemental correspondence thereto, which are incorporated into your , -, -, c - - - - -, _... - - - - - - - - - - - - --
s.
, < ' i l Alaska Radiological Pharmacy, Ltd.
2-license. A license fee may be charged for the amendments if you are not in a fee-exempt category.
6.
Maintain in a single document decommissioning records that have been certified for completeness and accuracy listing all the following iterm applicable to the license: Onsite areas designated or formerly designated as restricted areas as defined
in 10 CFR 20.3(a)(14) or 20.1003.
Onsite areas, other than restricted areas, where radioactive materials in
quantities greater than amounts listed in Appendix C to 10 CFR 20.1001-20.2401 have been used, possessed, or stored.
. Onsite areas, other than restricted areas, where spills or other unusual
occurrences involving the spread of contamination in and around the facility, equipment, or site have occurred that required reporting pursuant to 10 CFR 30.50(b)(1) or (b)(4), including areas where subsequent cleanup procedures have removed the contamination.
Specific locations and radionuclide contents of previous and current burial
areas within the site, excluding radioactive material with half-lives of 10 days or less, depleted uranium used only for shielding or as penetrators in unused munitions, or sealed sources authorized for use at temporary job sites.
Location and description of all contaminated equipment involved in licensed
operations that is to remain onsite after license termination.
7.
Submit a complete renewal application with proper fee, or termination request'at least 30 days before the expiration date on your license. You will receive a reminder notice approximately 90 days before the expiration date. Possession of radioactive material after your license expires is a violation of NRC regulations.
8.
Request termination of your license if you plan to permanently discontinue activities involving radioactive material.
You will be periodically inspected by NRC. Failure to conduct your program in accordance with NRC regulations, license conditions, and representations made in your license application and supplemental correspondence with NRC will result in enforcement action against you. This could include issuance of a notice of violation; imposition of a civil
..
... - - , Alaska Radiological Pharmacy, Ltd.
-3- . penalty; or..an' order suspending, modifying, or revoking your license as specified in the " General Statement of Policy and Procedure for NRC Enforcement Actions" (Enforcement ' Policy), 60 FR 34381, June 30,1995.
- .
]- - Thank ycu for your cooperation.
!
Sincerely, . ' James L. Montgomery J.
Senior Health Physicist ' Materials Branch i l < ' Docket: 030 34015 . License: 50-29096-01 MD Control: 572535 I i Enclosures: As stated I o I i
..
1.- i !
- d' . . Alaska Radiological Pharmacy, Ltd,
bec: Docket File , _ WCFO Inspection File-
LFARB, T 9 E10 l State of Alaska (License Only)
! !- ! I ,
DOCUMENT NAME: G:\\572535.JM - To receive copy of document, indicate in box: "C" = Copy without eglosures "E" = Copy with enclosures "N" = No copy RIV:MB-l RIV:MB l RIV:MB ffA l l K-Prendergast-BPrange JMontgom/P9 /. /97 / /97 y //M97 0FFICIAL RECORD COPY- -. - . . -.. . ... .. _ . _ - -. , -. _ - - -, _
_ _ . . -- . - m,2 m,3, n:40 so72434svo " gMM
. . - ,, .
ALASKA RADIOLOGICAL PHARMACY, LTD.
' 7... 2000 W. Int'l Airport Rd., Suite Al1, Anchorage, AK 99502 I:l*:. (907) 243-6377 * Fax (907) 243 4570 g,.79g
mil QQ-Sqgg ... e ; 7f2. 7[[? TIME SENT: DATE SENT: a frsr# 91.n/usr-rAxNuM ER: To: x Slo ~ ?7F 0%f COMPANY NAME:N C FROM: O COMPANY NAME: g f g g 7j/f-flts*S g AAC Tl/L CHsv&GC 7b T/fC 4 ZCCME's TM
v // E 0 0 4 y cela.vsc rs ~775'r 'voima g 7,[#g.7*' Th'C AKs7'* Of THC C *C Ge* S C w# 19C Mo 4 T)/E
Gh nf, Z IE *U CW 91}1n:TZ;^6
l40 R h.
AT YA'2;c f fax NO.: % 1y w I4ttCv W y, ( q cfy
p m,, py /WD "0 *l-O t7kK To possc pc FW.e um pg? $ DEsCRikN: N4/N / xv fsex ADLX 7b
at as c cse nn "- * = h a - ~~c
- " ",u A r c -rn r a cew1n w ep .p W ^^0 f** * q aa gut.c osmc.
iba-g c.e4 As rigccro r" Chcoarrnnch<1ew fMC ' '*T " ^^*'* NUMBER OF PAGES SENT Oncludingtover Sheet):
- NM
M,y'T rnvg-1747 :r cw te mer.1. a prm receivine g et raneminion pi.ae contact 4% Hr(, f%st w nc twev, 1//Ao/HS
Mue H Bc4H.'
- * " * *
s um war . !NS 5ZP535- -
~~i~TM/5sid997 a3: 40 9072434570 ARPx PAGE. 02 , i - - - , - , - hem 9 NRC-313 FACILITIES AND EQUIPMENT General Description Alaska Radiological Pharmacy will be located at 4201 Lake Otis Parkway, in Anchorage, - Alaska. '1he Pharmacy will be located in a one level wood building located in a medical neighborhood.
The generallsyout and site of the building nay be seen in attachment,9.1,9.2,and 9.3.
Restricted areas are outlined. Shielding and distance from regularly occupied work areas - are employed to ensintain exposures in accordance with the ALARA program. A separate lock system will be employed for the restricted area entrances to insure against unauthorized entry by non-radiation workers. All carriers will be instructed in the proper procedures for deliveries.
Secadty Security of radioactive material us nmintained to prevent unauthorized access when facility is closed by locking all entrances / nits when the plannecy is not attended. The building is equipped whh an intrusion alarm system connected to all operating entrances /exhs of the buikling and motion detector.' NON RESTRICTED AREA
- Ihe controlled area will cond2 of the rest of the pharmacy. All exits from the restricted areas into the non-restricted areas will be equipped with a hand and foot nxmitors, which will be used by personnel to check for contamination prior to exiting the restricted area.
,. -. _ _ ._
07/20/1997 12: 40 9072434570 App PARE 03 i , -. . . , , . Shielding , In accordance with the ALARA program, sulucient shleiding will be provided to keep the average whole body exposure rate in continuously occupied spaces at or telow 10 mrem per week. The " average" exposure rate shall be measured at not less than 0.5 meters from any radiation source. Areas which have low occupancy factors may be allowed to have higher exposure rates and willbe posted as radiation areas, but adjacent high occupancy areas shall be shickled as required.
Radiopharmaceuticals are stored in lead containers. This shickling is sufDcient to satisfy ALARA criteria. Additional shielding is used as necessary to reduce whole body exposure rates near stored noterials.
RESTRICTED AREA A. Generator Mo99/Ic99 generators in active service will be stored away form any side wall that may be frequented by any non-radiation worker. Each unit will be placed in the auxihary shielding supplied by the manufacturer, and are kept in a lead generator box.
Additional shielding will be used as necessary to satisfy ALARA criteria. Old generators may be transferred to a segregated waste storage area after expiration.
B. Waste Storage - The waste storage bins are constructed of 1/4" lead and have the capacity of approximately 50 gallons. The pharmacy will have 3 of these bins. Additioral shielding will be used as necessary to satisfy the ALARA criteria.
C. Preparation and Dispensing area - -Lead (1/2") and lead glass (1/4") dispensing stations are provided for the preparation, assay, and dispensing of radioactive materials.
Each dispersing area will be equipped with a dose calibrator,1/8" lead receptacle,12" forceps and syringe shields. A 1/8" thick lead sheet will be placed letween drawing stations, All radiopharmaceuticals will be dispensed in this area, which is located in the center of the facility in the restricted area. A refrigerator will be utilimi to store both radiopharmaceuticals, utilizing appropriate shiciding, and non-radioactive kits needing refrigeration.
. .
G7/85/1997 18: 40 9072424570 ARP PME 04
.
.- .
Item 9 NRC.113 Ite m 9.1 LETTER TO POLICE AND FIRE DEPARTMENT Date: Addms: Atteeilos: (Chief of Police) , (Chief of Fire) J Oentleman: We are required by the Nuclear Regulatory Conunission and/or the state of Alaska to notify you that we are utihzing radioactive materials under an NRC license at: Alaska Radiological Pharmacy,Ltd.
4201 Lake Otis Parkway Anchorage, Alaska 99508 (907) 563-7878 This notification is for your information in case of a fire or disaster which might involve l this building.
'Ihe material which we work is for use by physicians for medical purposes and tlerefore is comprised of short-lived radiopharmaceuticals.
Very little danger wouki exist in case of a fire or disaster, Imwever, precaution should be exercised by fire fighting personnel should it be necessary to enter the room in which the radioactive materialis stored. In the case of a fire, the nomslatile material woukt remain confined to this room due to the nature of this building's construction. Please see building layout,9.1,9.2, and 9.3, Should it become necessary to enter the pharmacy area. survey instruments are readily available, located in rooms adjacent to the radioactive storage room. Also, personnel trained in the use of survey instruments and familiar with hazardous radiation levels would be available to assist your Jersonnel.
If you have any quastions conceming this notification, or if you would hie to sisit our facility to familiarize yourself with our location, do not hesitate to contact us.
Sincerely, , -
07/25/1997 12: 40 9072434570 'ISE' ^ ^ ~ ~Mr[o~g~ ~
, i - - ., . . . . , t
i , e ................... 90y QMet eee - y P R ovi de nc t on t . A: Nw
d , ~ f! c* '
- '
o , l u d', %
j !j
f , , r i, ! '
, etianw ave n ,i ! l=; v.a. et a.....a e a
q .g ., _ r1 i - .... . k*oei l ll g> , d i f f l
- 'dfE
e
D
l KtMBERue c.
' ,
/7 l M,Ed r419l*l@4,Y; y e,,,,, i .l p! ' p.
8 j j i h.., Js ' is es , ,,,, ,,,, ' i ! sur le <<e n '
- (!Ank*'Ar!nonssgN_AL }g
,.,,,s cype nynw.
' N ~ $$ Y ?3 , ' "ll' "I l ? & M to u k'f#I-3;o $;5: . k,=Z y
.
g p0 d
- ,
Ig o
l l yf srtnaar - y ' " ' ' b .' ge, N, ,
- * * ' ' '
M* e
l l , ' ' -
C 'i Z AVE.
~ 7,** '%taa r eQ( g g /F) M'Fl'M khl m ! ',,, 'g sg
7l f, ,, o T., ,, .s
L r ,,
,, , ,, p. ) w....... j;l i b,3.- - SlL, /* % >=* u q iiip " rs a cv w AiPr - M
- "~5a u,
, ( w 8bU1h f b " 'Q 2 Q 2 8' O ' , ' fl * " 3" gy,, il-na no 0g "' f Ja[,o
Y j f Hela j n, y _p & ".' P-Jv el ,P V;PV1] r J 3.i a.,,jan u(ir; , , E , , no l ,y I f* * l
, '" I $ I" 3* g0 kle tc sie wac -- - - - M 811..T.
._ w ~ %L sk %y
- 12m
- i
! dm e has.<e QJaalw ,, f
80A A I 100 99 < * 101 ua=ea n.'-ac. u=a-a Y j c cormom ms un 115
I l l t . -. - - - - - -. - -
.- en2,x si, w ic ;rg,gigyg- - 3 - -- -- - - g 5 g - - - -- . 1twh4 6 9 %v' -x sq-p.samen y)
rq'a ,I
, , " ', , ' ,3 ' - - . . _ __
. , . li .- , , - a . . .th-(. ~e L K, g
. e.,e . , , . . . , h k --
' _ g . _z.,.,#p 1 -- a.
- - - - -, , , 4'. o ' ? ' n' p.',
linq\\{
_ A( ' %, l ' ,
0-L - ' ) n%' . -
' ' - . .rm m- ,e,.. . _.
, "" B l . - , ( N N4 i
i n
.; w L.
.
r, ........ - -... J ,, ee w.. e n 3,4 .u_s a - . .. EW1 YFF" -.J.go p g3p M g;gg y g yg g p g 'h ' < ,-x. . - - ' i ,il _ g- ,
1.g ... j DfpSIM > , l L IlooM ' , } ] ' i . . l h, J:r @ :== h Aq % < - i %
i / , , < e n j / 0)?'F 1: -
a
, P
g . i '
I D .b-Cf-b ' ' g -- -- . ..... . ~.... ' fl ' . . . . N h.
u I
07/25[1997 52540 9072434570 MP put 07 . '
. -,. 'Ik. Q~ ._ 3 _ w.
, m-c %*.*-.8 ' r**: F
o $l l , y 6,lAST.5 $TEUU' '*l f.
, }g , f[';( f ' ' ' '
. . . . a. - t e > l _ ._ , - . $ , ' ' g% ," f >.77Nf MM ' . ll , e. pa , e.
. gun.
. . .' . i t iP(n,.s/ ilei j / , -
- 6
' f.
i , _ t ,,,. ~~ lV r , . l.
- l M. ' n' . , I ( 04%U1Til A '54 '. ' . -
4 we,, ,13 - g.~. _. - =. -, _, >m . n l ' a - . 4, o,, , ,, .i ..k.. .. -. - n,.: 9... ' < . '
j J l . ,' II h
Y ~ ,\\' ' ' ) '. .. . .- . . E** t*d
l* , g \\ ~ J- - . , N - \\ k (, _ s _ ._ l
m ' " ,7
......---... l ,/ ' &. ~s ,e r = - *-~ ' L ma % ):- . .WL > .. ... ' d
i , s_.... t.
d F% hr.
, ' ' L , ,
7 n_.
z, g77 9 y - ............f,h}D6Esstis_.
- R o o41 ' ' t_ - ,: r-If
s
s ) - r i - _ ,c .._ * . ..' I i ! , t=e L .. _.
. . . . . .. - _ _ _ _ _
/W GW25/1997 12: 40 9072434570 (M' .* PN'E 00 o . - , , CROSSON and ASSOCIATES . NEIGIIJ3ORHOOD MAP
- '.
,,,e.., n us,, ro., ,'
pfCManegow ,, M M g({g" "'T # e , ~v I' _ Avg
. T%'*'. ' ssen 4,, g .a ; p f
6m 47, O , e S%%k*.a I . ~ W Of84pa av yp a-y:n ", M %
g n,,,,r ... < s u+e - : ym , m <- I f , - - y,- _
- l h
e <sv. ,,,, 4 !SA A ave l t t
y g# - f (: = -
t, i } , .. T ~ f , , , /}
~a , \\ ' * ' ' " - -**T'O ATipn, - as q a, l. ,o u h g , asper ., , , '
, o U
h > h k E I I ! . j {
3 g , b(; N '
! f gg tOj
a... , .. ) o,.o.,,,, w , _ g3nig ,-._
- *
. ( 0'w att r y ,, g**c'4 n , k 5 o
Q_ - t
y . _ -\\ "veruan ,, '%
%
.... _ \\ - .,,... -.. l . . 23 }}